Cryopreserve and bank primary blood-cancer samples with the processing, tracking, and post-thaw checks that xCellSense® testing relies on — so the samples you collect today can answer new questions later.
Primary patient samples are finite. Banking viable aliquots during your study lets you return to the same patients' cells for new compounds, combinations, or readouts as your program evolves — often without a new round of collection.
.svg)
Primary cells are processed and cryopreserved under controlled conditions, then checked for post-thaw viability before any functional testing.
Every aliquot is tracked and retrievable, linked to the sample and clinical information available for your study.
Re-test stored aliquots with new agents, relate response to clinical outcomes where available, or compare samples taken at different time points.
A planned banking strategy extends the value of each sample, supports retrospective analyses, and can reduce the time and cost of sourcing new material. What you can test later depends on the quantity and quality of what you store — we help you plan for both.
Key Deliverables
Tell us which samples you expect to collect and which assays you plan to run. A scientist will scope a banking and testing plan with you.
